SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,480.29 -48.78
( -0.07%)

Global Indices

Nasdaq

51,369.65 -132.86
(-0.26%)

Dow Jones

7,690.99 -13.70
(-0.18%)

Hang Seng

66,863.07 1,381.80
(2.11%)

Nikkei 225

10,628.22 -56.66
(-0.53%)

Forex

USD-INR

95.96 0.17
(0.18%)

EUR-INR

109.15 0.06
(0.06%)

GBP-INR

127.16 0.33
(0.26%)

JPY-INR

0.61 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

93.2373503

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

140.17

446276.3

EPS(TTM)

Face Value()

Div & Yield %

13.27

0.86

Back

Cholamandalam Investment & Finance Company consolidated net profit rises 45.56% in the June 2026 quarter

Jul 28,2026

Net profit of Cholamandalam Investment & Finance Company rose 45.56% to Rs 1656.22 crore in the quarter ended June 2026 as against Rs 1137.83 crore during the previous quarter ended June 2025. Sales rose 21.87% to Rs 8856.29 crore in the quarter ended June 2026 as against Rs 7266.80 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	8856.29	7266.80	22
OPM %	70.05	68.54	-
PBDT	2298.62	1599.44	44
PBT	2223.56	1532.00	45
NP	1656.22	1137.83	46

72,480.29 -48.78 ( -0.07%)

51,369.65 -132.86 (-0.26%)

7,690.99 -13.70 (-0.18%)

66,863.07 1,381.80 (2.11%)

10,628.22 -56.66 (-0.53%)

95.96 0.17 (0.18%)

109.15 0.06 (0.06%)

127.16 0.33 (0.26%)

0.61 0.00 (0.14%)